Login / Signup

Selective granulocyte-monocyte apheresis during induction with vedolizumab in moderate-severe ulcerative colitis: Experience in a tertiary hospital.

Cristina Suárez FerrerEduardo Martin-ArranzMaría Dolores Martín-Arranz
Published in: Gastroenterologia y hepatologia (2024)
GMA+VDZ during induction can be effective and safe in selected patients with moderate-severe UC and partial response to steroids.
Keyphrases
  • ulcerative colitis
  • high intensity
  • early onset
  • peripheral blood
  • endothelial cells
  • patients with inflammatory bowel disease